GSK sees blockbuster potential in targeted cancer therapy after promising early data WSAU
Encouraging Activity in Poor-Risk Endometrial Cancer With HER2-Targeted Novel Drug MedPage Today
GSK presents positive data for B7-H4-targeted ADC in gynecological cancers GSK US
GSK presents positive data for B7-H4-targeted ADC in gynecological cancers GSK
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers National Today
In ovarian cancer, one drug target towers up to 100-fold above rivals Stock Titan
Endometriosis and endometrial cancer are distinct gynecological conditions that share overlapping biological mechanisms with implications for clinical management. Endometriosis is a chronic, benign disorder characterized by the ectopic implantation of …
Endometriosis, a prevalent gynecological disease affecting women's health, involves altered immune function. This study investigates the immune checkpoint protein, V-domain immunoglobulin suppressor of T cell activation (VISTA) as a therapeutic …
Oocyte quality, a critical determinant of female reproductive potential, experiences a progressive decline with age, largely driven by the cumulative effects of oxidative stress and mitochondrial dysfunction. This review thoroughly …
"Targeted supports" launched for former patients of Simon Gordon HospitalHealth.com.au